# Brigitte Wildemann

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/brigitte-wildemann/

## Facts

| Field | Value |
| --- | --- |
| Citations | 23,229 |
| Field | Multiple Sclerosis Research Studies |
| h-index | 75 |
| i10-index | 246 |
| Last Known Institution | Heidelberg University |
| OpenAlex ID | https://openalex.org/A5011686938 |
| ORCID iD | https://orcid.org/0000-0002-5389-3338 |
| Works | 402 |

## Researcher papers

- [MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome](https://scholariq.org/papers/mog-igg-in-nmo-and-related-disorders-a-multicenter-study-of-50-patients-part-2/)
- [Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients](https://scholariq.org/papers/contrasting-disease-patterns-in-seropositive-and-seronegative-neuromyelitis/)
- [MOG encephalomyelitis: international recommendations on diagnosis and antibody testing](https://scholariq.org/papers/mog-encephalomyelitis-international-recommendations-on-diagnosis-and-antibody/)
- [Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)](https://scholariq.org/papers/update-on-the-diagnosis-and-treatment-of-neuromyelitis-optica-recommendations-of/)
- [MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome](https://scholariq.org/papers/mog-igg-in-nmo-and-related-disorders-a-multicenter-study-of-50-patients-part-3/)
- [MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients](https://scholariq.org/papers/mog-igg-in-nmo-and-related-disorders-a-multicenter-study-of-50-patients-part-4/)
- [Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management](https://scholariq.org/papers/update-on-the-diagnosis-and-treatment-of-neuromyelitis-optica-spectrum-disorders/)
- [Apheresis therapies for NMOSD attacks](https://scholariq.org/papers/apheresis-therapies-for-nmosd-attacks/)
- [Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis](https://scholariq.org/papers/update-on-the-diagnosis-and-treatment-of-neuromyelits-optica-spectrum-disorders/)
- [Low-Frequency and Rare-Coding Variation Contributes to Multiple Sclerosis Risk](https://scholariq.org/papers/low-frequency-and-rare-coding-variation-contributes-to-multiple-sclerosis-risk/)

## Researcher topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Autoimmune Neurological Disorders and Treatments](https://scholariq.org/topics/autoimmune-neurological-disorders-and-treatments/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [T-cell and B-cell Immunology](https://scholariq.org/topics/t-cell-and-b-cell-immunology/)

## Researcher university

- [Heidelberg University](https://scholariq.org/institutions/heidelberg-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.